These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 24467943)

  • 1. Antipsychotic dosing: found in translation.
    Remington G; Fervaha G; Foussias G; Agid O; Turrone P
    J Psychiatry Neurosci; 2014 Jul; 39(4):223-31. PubMed ID: 24467943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the individual safe correction of antipsychotic agent polypharmacy in Japanese patients with chronic schizophrenia: validation of safe corrections for antipsychotic polypharmacy and the high-dose method.
    Yamanouchi Y; Sukegawa T; Inagaki A; Inada T; Yoshio T; Yoshimura R; Iwata N
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional antipsychotic medications for schizophrenia.
    Dixon LB; Lehman AF; Levine J
    Schizophr Bull; 1995; 21(4):567-77. PubMed ID: 8749885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for dosing and switching antipsychotics for optimal clinical management.
    Buckley PF; Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic dosing: how much but also how often?
    Remington G; Kapur S
    Schizophr Bull; 2010 Sep; 36(5):900-3. PubMed ID: 20650931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent advances in clinical psychopharmacology].
    Mori A
    Yakubutsu Seishin Kodo; 1984 Nov; 4(3):201-12. PubMed ID: 6152505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting age-specific dosing of antipsychotics.
    Uchida H; Pollock BG; Bies RR; Mamo DC
    Clin Pharmacol Ther; 2009 Oct; 86(4):360-2. PubMed ID: 19763115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Extended" antipsychotic dosing in the maintenance treatment of schizophrenia: a double-blind, placebo-controlled trial.
    Remington G; Seeman P; Feingold A; Mann S; Shammi C; Kapur S
    J Clin Psychiatry; 2011 Aug; 72(8):1042-8. PubMed ID: 20868639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia.
    Marteene W; Winckel K; Hollingworth S; Kisely S; Gallagher E; Hahn M; Ebdrup BH; Firth J; Siskind D
    Expert Opin Drug Saf; 2019 Dec; 18(12):1149-1160. PubMed ID: 31564170
    [No Abstract]   [Full Text] [Related]  

  • 10. [Schizophrenia, diabetes mellitus and antipsychotics].
    Gury C
    Encephale; 2004; 30(4):382-91. PubMed ID: 15538314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy review of antipsychotics.
    Krausz M
    Curr Med Res Opin; 2002; 18 Suppl 3():s8-12. PubMed ID: 12418606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Optimal Antipsychotic Dose and Dosing Interval in the Treatment of Schizophrenia].
    Takeuchi H
    Seishin Shinkeigaku Zasshi; 2015; 117(7):562-7. PubMed ID: 26552322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational pharmacotherapy in early psychosis.
    Remington G
    Br J Psychiatry Suppl; 2005 Aug; 48():s77-84. PubMed ID: 16055813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacology of schizophrenia in children and adolescents.
    Carlisle LL; McClellan J
    Pediatr Clin North Am; 2011 Feb; 58(1):205-18, xii. PubMed ID: 21281857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of psychopharmacotherapy in improving the long-term outcome of schizophrenia.
    Alam DA; Janicak PG
    Essent Psychopharmacol; 2005; 6(3):127-40. PubMed ID: 15869020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry.
    Kane JM; Kishimoto T; Correll CU
    J Clin Epidemiol; 2013 Aug; 66(8 Suppl):S37-41. PubMed ID: 23849151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching long acting antipsychotic medications to aripiprazole long acting once-a-month: expert consensus by a panel of Italian and Spanish psychiatrists.
    Fagiolini A; Alfonsi E; Amodeo G; Cenci M; Di Lella M; Farinella F; Ferraiuolo F; Fraguas D; Loparco N; Gutierrez-Rojas L; Mignone ML; Pataracchia G; Pillai G; Russo F; Sanchez-Gistau V; Spinogatti F; Toscano M; Villari V; De Filippis S
    Expert Opin Drug Saf; 2016; 15(4):449-55. PubMed ID: 26886162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosing of antipsychotics in schizophrenia across the life-spectrum.
    Uchida H; Mamo DC
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):917-20. PubMed ID: 19426777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of schizophrenia: Can we raise the standard of care?
    Catts SV; O'Toole BI
    Aust N Z J Psychiatry; 2016 Dec; 50(12):1128-1138. PubMed ID: 27821411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.